within Pharmacolibrary.Drugs.ATC.B;

model B02BD30
  extends Pharmacokinetic.Models.PK_1C_enteral(
    weight         = 70,
    F              = 1,
    Cl             = 3.6 / 1000 / 60,
    adminDuration  = 600,
    adminMass      = 5000 / 1000000,
    adminCount     = 1,
    Vd             = 7.000000000000001e-05,
    Cmin           = 0.001,
    Cmax           = 0.01,
    Ctox_peak      = 0.02,
    Ctox_trough    = 0.01,
    ka             = 0.016666666666666666,
    Tlag           = 600
  );

  annotation(Documentation(
    info ="<html><body><p>Thrombin is a serine protease enzyme that plays a central role in the coagulation cascade, converting fibrinogen to fibrin and thus promoting blood clot formation. It is used medicinally as a topical hemostatic agent to control bleeding during surgeries or trauma. Thrombin for systemic use is not approved due to its rapid neutralization by antithrombin and potential for severe coagulopathy.</p><h4>Pharmacokinetics</h4><p>Estimated pharmacokinetic parameters for exogenous human thrombin administered intravenously in healthy adult patients, as direct clinical PK studies are not available.</p><h4>References</h4><ol><li><p>Gelbenegger, G, &amp; Jilma, B (2022). Clinical pharmacology of antiplatelet drugs. <i>Expert review of clinical pharmacology</i> 15(10) 1177–1197. DOI:<a href=&quot;https://doi.org/10.1080/17512433.2022.2121702&quot;>10.1080/17512433.2022.2121702</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/36065676/&quot;>https://pubmed.ncbi.nlm.nih.gov/36065676</a></p></li><li><p>Garcia, DA, et al., &amp; Samama, MM (2012). Parenteral anticoagulants: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. <i>Chest</i> 141(2 Suppl) e24S–e43S. DOI:<a href=&quot;https://doi.org/10.1378/chest.11-2291&quot;>10.1378/chest.11-2291</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/22315264/&quot;>https://pubmed.ncbi.nlm.nih.gov/22315264</a></p></li><li><p>Radulescu, VC (2017). Anticoagulation Therapy in Children. <i>Seminars in thrombosis and hemostasis</i> 43(8) 877–885. DOI:<a href=&quot;https://doi.org/10.1055/s-0036-1598004&quot;>10.1055/s-0036-1598004</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/28346967/&quot;>https://pubmed.ncbi.nlm.nih.gov/28346967</a></p></li></ol></body></html>",
    revisions = "<html><body><ul><li>06/2025 model generated by LLM gpt-4.1, references by scholarly and scripts created by Tomas Kulhanek</li></ul></body></html>"
  ));
end B02BD30;
